$Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy$

Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy

Purpose: Our purpose was to study the outcomes of hypofractionated stereotactic radiation therapy (HSRT) in terms of hearing and radiologic response for vestibular schwannomas. Methods and Materials: This was a longitudinal retrospective study at a referral center from 2011 to 2016. All treatments w...

Full description

Bibliographic Details
Main Authors:	Pierre-Marie Pialat, MD, Maxime Fieux, MD, Stéphane Tringali, MD, PhD, Guillaume Beldjoudi, PhD, Pascal Pommier, MD, PhD, Ronan Tanguy, MD
Format:	Article
Language:	English
Published:	Elsevier 2021-07-01
Series:	Advances in Radiation Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S245210942100052X

Similar Items

Refractory communicating hydrocephalus after radiation for small vestibular schwannoma with asymptomatic ventriculomegaly: A case report
by: Masahiro Nakahara, MD, et al.
Published: (2020-07-01)

Magnetic Resonance-Guided Stereotactic Body Radiation Therapy/Hypofractionated Radiation therapy for Metastatic and Primary Central and Ultracentral Lung Lesions
by: Maria L. Sandoval, MD, MS, et al.
Published: (2023-05-01)

Vestibulocochlear Delineation for Vestibular Schwannoma Treated With Radiation Therapy
by: Felipe Cicci Farinha Restini, MD, et al.
Published: (2023-07-01)

Malignant transformation of vestibular schwannoma after radiation therapy
by: Anastasia Drakos, BHSc, et al.
Published: (2024-07-01)

Tufts Medical Center Experience With Long-Term Follow-Up of Vestibular Schwannoma Treated With Gamma Knife Stereotactic Radiosurgery: Novel Finding of Delayed Pseudoprogression
by: Justin Wage, MD, et al.
Published: (2021-07-01)

Vestibular schwannoma with fluid-fluid levels mimicking aneurysm bone cyst
by: Ho Xuan Tuan, MD, PhD, et al.
Published: (2023-03-01)

Definitive hypofractionated radiation therapy for early stage breast cancer: Dosimetric feasibility of stereotactic ablative radiotherapy and proton beam therapy for intact breast tumors
by: Jonathan W. Lischalk, MD, et al.
Published: (2018-07-01)

Tumor-Associated Macrophages in Vestibular Schwannoma and Relationship to Hearing
by: Eric Nisenbaum MD, et al.
Published: (2021-11-01)

Early Tolerance Outcomes of Stereotactic Hypofractionated Accelerated Radiation Therapy Concomitant with Pelvic Node Irradiation in High-risk Prostate Cancer
by: Attapol Pinitpatcharalert, MD, et al.
Published: (2019-04-01)

Malignant transformation of a vestibular schwannoma to malignant peripheral nerve sheath tumor 10 years after Gamma Knife Surgery: Case report
by: Irwan Barlian Immadoel Haq, M.D., et al.
Published: (2019-12-01)

Spatially fractionated stereotactic body radiation therapy (Lattice) for large tumors
by: Sai Duriseti, MD, PhD, et al.
Published: (2021-05-01)

Single and Multifraction Spine Stereotactic Body Radiation Therapy and the Risk of Radiation Induced Myelopathy
by: J. John Lucido, PhD, et al.
Published: (2022-11-01)

Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac
by: Stefania Naccarato, PhD, et al.
Published: (2022-05-01)

Long-term Treatment Response and Patient Outcomes for Vestibular Schwannoma Patients Treated with Hypofractionated Stereotactic Radiotherapy
by: Mira A. Patel, et al.
Published: (2017-09-01)

Stereotactic radiosurgery for vestibular schwannomas
by: Braunstein S, et al.
Published: (2018-09-01)

Effect of Target Changes on Target Coverage and Dose to the Normal Brain in Fractionated Stereotactic Radiation Therapy for Metastatic Brain Tumors
by: Hideharu Miura, PhD, et al.
Published: (2023-11-01)

Fractionated stereotactic radiation therapy for intact brain metastases
by: Samuel R. Marcrom, MD, et al.
Published: (2017-10-01)

Radiation-Induced Peripheral Neuropathy After Thoracic Stereotactic Ablative Radiotherapy: Case Report
by: Ha H. Pham, MD, PhD, et al.
Published: (2022-08-01)

Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost in Patients With Spinal Metastases
by: Antonio Pontoriero MD, et al.
Published: (2020-04-01)

Brain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgery
by: Ingrid Digernes, MSc, et al.
Published: (2018-10-01)

A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy
by: Krishnan R. Patel, MD, et al.
Published: (2022-11-01)

Recent Advances and Challenges in Stereotactic Body Radiotherapy
by: Atsuto Katano MD, PhD, et al.
Published: (2024-02-01)

Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions
by: David Boyce-Fappiano, MD, MHM, et al.
Published: (2022-05-01)

Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Multiple Pulmonary Oligometastases or Synchronous Primary Lung Cancer
by: Noriko Kishi, MD, et al.
Published: (2022-05-01)

Adjuvant treatment of meningioma with stereotactic radiation surgery and hypofractionated stereotactic radiation surgery: Patterns of care and survival in a large, hospital database
by: Ashley Albert, MD, et al.
Published: (2018-07-01)

Gamma Knife Treatment of Vestibular Schwannoma Planned With Computed Tomography Cisternography
by: Austin J. Livingston, MD, et al.
Published: (2021-05-01)

Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy
by: Dawn Owen, MD, PhD, et al.
Published: (2016-01-01)

Stereotactic Radiation Therapy for an Arteriovenous Malformation of the Oral Tongue: A Teaching Case
by: Emily C. Merfeld, MD, et al.
Published: (2022-05-01)

Single-Institution Prospective Evaluation of Moderately Hypofractionated Whole-Breast Radiation Therapy With Simultaneous Integrated Boost With or Without Lymphatic Drainage Irradiation After Breast-Conserving Surgery
by: Olga Unterkirhere, MD, PhD, et al.
Published: (2023-11-01)

Evaluation of DIBH and VMAT in Hypofractionated Radiotherapy for Left-Sided Breast Cancers After Breast-Conserving Surgery: A Planning Study
by: Liuwei Tang MD, et al.
Published: (2021-10-01)

Novel Postoperative Hypofractionated Accelerated Radiation Dose-Painting Approach for Soft Tissue Sarcoma
by: Matthew Mills, MD, et al.
Published: (2024-03-01)

Single fraction stereotactic radiosurgery for multiple brain metastases
by: Dror Limon, MD, et al.
Published: (2017-10-01)

Comparable Long-Term Tumor Control for Hypofractionated FLASH Versus Conventional Radiation Therapy in an Immunocompetent Rat Glioma Model
by: Elise Konradsson, MSc, et al.
Published: (2022-11-01)

An Analysis of Clinical Toxic Effects and Quality of Life as a Function of Radiation Dose and Volume After Lung Stereotactic Body Radiation Therapy
by: Suneetha Devpura, PhD, et al.
Published: (2021-11-01)

Effect of Large Prostate Volume on Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy in Patients With Prostate Cancer
by: Divya Natesan, MD, et al.
Published: (2022-03-01)

Schwannoma arising in a lymph node mimicking metastatic pulmonary carcinoma
by: Mitsuhiro Kamiyoshihara, MD., PhD., et al.
Published: (2018-01-01)

Radiation Therapy Practice Patterns for Brain Metastases in the United States in the Stereotactic Radiosurgery Era
by: Andrew B. Barbour, PhD, et al.
Published: (2020-01-01)

Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trial
by: K. Ranh Voong, MD MPH, et al.
Published: (2017-07-01)

Tumor Lysis Syndrome in a Patient With Metastatic Endometrial Cancer Treated With Lattice Stereotactic Body Radiation Therapy
by: Joshua P. Schiff, MD, et al.
Published: (2022-01-01)

Challenges and Opportunities With the Use of Hypofractionated Radiation Therapy in Cancer Care: Regional Perspectives From South Korea, Japan, Singapore, and Australia
by: Tetsuo Akimoto, MD, et al.
Published: (2023-11-01)